Daily Stock List
Neurotrope, Inc. (NTRP)
SmallCapVoice reported this month on Neurotrope, Inc. (NTRP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Neurotrope, Inc. is a specialty biopharmaceutical company that lists on the OTCQB. Neurotrope Bioscience, Inc. is the operating subsidiary of Neurotrope, Inc. Neurotrope Bioscience was established in October of 2012 mainly to license, develop, and commercialize various novel therapeutic and diagnostic technologies from the Blanchette Rockefeller Neuroscience Institute (BRNI) focused on the development of conventional small molecules, which are extraordinarily potent in the activation of the enzyme PKCe. Neurotrope is headquartered in Newark, New Jersey.
PKCe has been shown to play a central role in the regrowth or repair of nervous tissues, cells, or cell products. The Company’s pipeline, under its license from BRNI, includes the drug candidate, bryostatin, for the treatment of Alzheimer's disease. It also includes a minimally invasive, diagnostic biomarker analysis system that would assess the presence of Alzheimer's in patients.
Moreover, Neurotrope has a global, exclusive license agreement with the Icahn School of Medicine at Mount Sinai located in New York, New York to use its proprietary information and data package for the use of bryostatin-1 in the treatment of Niemann-Pick Type C Disease. This is a rare disease, mostly of children who are afflicted with Alzheimer-like symptoms.
Furthermore, Neurotrope, under its BRNI license, has the rights to develop the licensed technology for other cognitive dysfunctions. This includes orphan diseases, such as Fragile X Syndrome. BRNI, at West Virginia University, is a unique, independent, non-profit institute committed to the study of memory and finding solutions to memory disorders.
This month, Neurotrope announced secondary and exploratory endpoint results from its randomized, double-blind, placebo-controlled, single dose Phase 2a clinical trial evaluating bryostatin-1 for the treatment of Alzheimer's disease (AD). The study reveals preliminary evidence of target engagement of PKCe that Neurotrope believes is critical to improving cognitive function. It plans to move to an expanded Phase 2b study with 150 AD patients. Neurotrope is approaching the treatment of Alzheimer's disease through the activation of PKCe.
Through its partnerships with BRNI and Stanford University, Neurotrope believes it is uniquely positioned to develop next generation therapeutics. The Company has a library of over 70 drug candidates, including Bryostatin-1. Neurotrope is seeking to slow down or reverse the underlying pathologies that lead to neurodegeneration, synaptic dysfunction, as well as behavioral abnormalities.
Neurotrope, Inc. (NTRP), closed Tuesday's trading session at $1.21, up 1.68%, on 38,439 volume with 43 trades. The average volume for the last 60 days is 31,085 and the stock's 52-week low/high is $0.50/$2.00.
Cardinal Resources, Inc. (CDNL)
Lions of Wall Street, Bull Trends, Juicy Penny Stocks, and Greenbackers reported on Cardinal Resources, Inc. (CDNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTC Bulletin Board-listed Cardinal Resources, Inc. produces and distributes water and wastewater treatment systems. These include the solar powered Red Bird System and natural media filters. Founded in October of 2004, Cardinal Resources has its corporate headquarters in Pittsburgh, Pennsylvania.
In 2014, Cardinal Resources concentrated on completing the transition from its legacy global environmental remediation business to its water treatment business, producing the industry-leading "Red Bird" family of patented, solar-powered, community-scale mobile and fixed-location drinking water systems.
The Red Bird System is an approach for bringing clean water to underserved communities worldwide. Red Bird is a patented, high-technology, rapid-deployment green energy solution. The design of it is to function in the harsh, low-tech environment pervasive throughout developing nations around the world.
The Company recognized a serious need for communities in the developing world to have a simple, reliable, as well as sustainable method of producing clean drinking water. Cardinal’s approach was to design and deliver a robust, solar powered system that utilizes no pre-treatment chemicals and requires very little maintenance.
The Red Bird System produces tens of thousands of gallons of clean water daily from any fresh water (non-saline) source at a fraction of a cent per gallon. Cardinal Resources trains local people to maintain and operate the systems so that safe water will be sustainable for years in the future. Red Bird’s high output produces enough water for a community. Moreover, automation and controls provide many safeguards for water quality and safety.
The Red Bird System has an integrated pump to take water from the source. It also has granular filters that last for years and on-site chlorine generation. It can pump water to a storage tank up to 30 feet high.
Cardinal Resources has an international presence. It has worked in more than 30 countries. It is currently selling its Red Bird System into key emerging markets in Sub-Saharan Africa, Latin American, as well as Asia.
Cardinal Resources, Inc. (CDNL), closed Tuesday's trading session at $0.08, up 1.27%, on 103,096 volume with 15 trades. The average volume for the last 60 days is 316,928 and the stock's 52-week low/high is $0.07/$2.00.
Cryoport, Inc. (CYRX)
TopPennyStockMovers reported yesterday on Cryoport, Inc. (CYRX), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Cryoport, Inc. is the leading provider of advanced cryogenic logistics solutions for life sciences. The markets it serves include immunotherapies, stem cells, cell lines, clinical research organizations (CROs), vaccine manufacturers, as well as reproductive medicine. With its purpose-built proprietary packaging, information technology (IT), and specialized cold chain logistics expertise, Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry. The Company has offices in Lake Forest and San Diego, California. Cryoport’s shares trade on the OTC Bulletin Board.
The Company provides pioneering logistics solutions for biologic materials, including immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients around the world. These clients include points-of-care, CRO's, central laboratories, pharmaceutical companies, contract manufacturers, and university researchers.
Cryoport’s packaging is built around its proprietary Cryoport Express® liquid nitrogen dry vapor shippers. These are validated to maintain a constant -150°C temperature for a 10 day dynamic shipment duration. Cryoport’s IT centers on its Cryoportal™ Logistics Management Platform. This Platform facilitates management of the total shipment process.
The Cryoport solution is a cost-effective, advanced, end-to-end solution for shipping frozen biological materials. The system combines a unique pre-packaged LN2-vapor dry shipper with web-based Cryoportal™ ordering technology and global logistics management to track and monitor the integrity of frozen shipments worldwide.
Last month, Cryoport announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections. The Company is providing complete logistics management for the relocation of a leading research laboratory and IVF clinic. All material shipping and transport is supervised and performed by trained personnel under compliance with DOT, CDC and IATA regulations.
Today, Cryoport announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom (UK). This is in support of Roslin's induced pluripotent stem cell (iPSC) reprogramming service.
Mr. Jerrell Shelton, Cryoport's Chief Executive Officer, stated, "As we further expand our operations in the European Union, Cryoport takes great pride in having the opportunity to support Roslin Cells in its continuing development and manufacture of pluripotent stem cells for the life sciences community. This relationship builds on our success to support leading cell therapy programs and demonstrates our position in regenerative medicine in Europe. Cryoport believes that iPSC research will play a significant role in developing therapeutic options for patients into the future and we are delighted to support Roslin Cells in our critical cryogenic logistics role."
Cryoport, Inc. (CYRX), closed Tuesday's trading session at $0.72, up 2.86%, on 81,289 volume with 48 trades. The average volume for the last 60 days is 44,001 and the stock's 52-week low/high is $0.31/$0.87.
Bio-AMD, Inc. (BIAD)
We are highlighting Bio-AMD, Inc. (BIAD) today, here at the QualityStocks Daily Newsletter.
Bio-AMD, Inc. has two majority owned United Kingdom (UK) subsidiaries. One is Bio Alternative Medical Devices Ltd., which is a technology developer for medical diagnostic devices. The other is WOCU Limited, the owner of the WOCU®, an international currency data reference source for application in financial markets. The Company has positioned itself as a foremost innovator in the field of reader technology development. Bio-AMD lists on the OTC Markets’ OTCQB.
Concerning WOCU®, it is a global composite currency derivative covering the world’s top 20 economies. It is weighted sophisticatedly and logically based on International Monetary Fund (IMF) GDP figures. The WOCU’s low volatility offers market professionals and individuals a natural currency stabilization, hedging against exchange rate volatility and individual currency purchasing power.
Bio-AMD is the 63 percent owner of Bio Alternative Medical Devices Ltd., a technology development company positioned in the fast growing Point of Care (PoC) medical diagnostics sector. PoC medical diagnostics is a multi-billion dollar worldwide market.
At present, Bio-AMD has three proprietary technology platforms. These technology platforms include a disposable micro-fluidic test strip, which has been adapted to measure prothrombin time (PT)/INR through a PoC blood coagulation monitoring device (COAG) enabling patient based, anticoagulant drug therapy monitoring.
The Company’s platforms also include a Digital Strip Reader (DSR). It can read a broad variety of lateral flow based immunoassay diagnostic test strips already in the PoC market including, but not limited to, cardiac markers, infectious diseases, drugs of abuse, and female wellbeing (pregnancy/ovulation testing) to provide semi-quantitative results.
The DSR technology platform employs a patented, proprietary method for reading and quantifying traditional chromatography based, nitro-cellulose, lateral-flow immunoassay tests, focused on what the Company believes to be a unique optical sensor arrangement. The DSR consists of a proprietary design incorporating sensors, diagnostics, and display and power management capabilities.
Furthermore, Bio-AMD is developing a fully quantitative Magnetic Immunoassay Detection System (MIDS). Its expectation is that this will have a considerably enhanced sensitivity based on magnetic nano-particle manipulation and detection, which can interpret results on a quantitative basis. Initially, the Company plans to develop MIDS for a panel of POC cardiac marker tests, such as troponin (cTnI or cTnT), myoglobin and creatine kinase MB isoenzyme (CK-MB), used to diagnose myocardial infarction (heart attack) and its severity. Its ultimate goal is to commercialize a product for the multiple cardiac marker testing market.
Bio-AMD, Inc. (BIAD), closed Tuesday's trading session at $0.203, up 1.50%, on 80,600 volume with 10 trades. The average volume for the last 60 days is 176,241 and the stock's 52-week low/high is $0.0201/$0.30.
Diadexus, Inc. (DDXS)
Streetwise Reports, MomentumOTC, Pumps and Dumps, and PennyStocks24 reported earlier on Diadexus, Inc. (DDXS), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Diadexus, Inc. is a commercial stage developer of proprietary cardiovascular diagnostic products. It develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. Diadexus is ISO 13485 certified. The Company lists on the OTC Markets Group’s OTCQB. Diadexus is headquartered in South San Francisco, California.
The Company pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation, which provides new information, over and above traditional risk factors measured in a lipid panel, and has more than ten years of peer-reviewed literature validating this biomarker's utility.
Its PLAC® Test ELISA Kit is the only blood test cleared by the U.S. Food and Drug Administration (FDA) to aid in predicting risk for coronary heart disease and ischemic stroke associated with atherosclerosis. Its PLAC® Test for Lp-PLA2 Activity, a CE-marked test, is an indicator of atherosclerotic cardiovascular disease. Diadexus manufactures the PLAC® Test for Lp-PLA2 Activity on-site.
The PLAC Test for Lp-PLA2 Activity is an enzyme assay for the quantitative determination of Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) activity in human plasma and serum. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) is a vascular-specific inflammatory marker, which is critical in the formation of rupture-prone plaque. When elevated, this enzyme indicates arterial inflammation, which is associated with greater risk for cardiovascular disease.
Diadexus also has a pipeline of biomarkers for heart failure. These are proADM, proET-1 and proANP. Each provides distinct, additive information for healthcare providers over presently available markers. In addition, the Company provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development.
Last week, Diadexus announced results from the PLAC® Test for Lp-PLA2 Activity (PLAC® Activity Test) clinical validation study, presented for the first time on March 24, 2015 during an oral presentation at the European Atherosclerosis Society 83rd Congress in Glasgow, United Kingdom (UK). The results from this study were used in the 510(k) submission for this new test (cleared by the U.S. Food and Drug Administration in December 2014) for use in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events.
Diadexus, Inc. (DDXS), closed Tuesday's trading session at $0.415, up 3.75%, on 49,400 volume with 18 trades. The average volume for the last 60 days is 132,651 and the stock's 52-week low/high is $0.2813/$1.10.
Green Technology Solutions, Inc. (GTSO)
SmallCapVoice and PennyStocks24 reported on Green Technology Solutions, Inc. (GTSO), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
San Jose, California-headquartered Green Technology Solutions, Inc. provides business support, delivery system products, and horticultural technology support. A cannabis technology innovator, it explores the fast-growing cannabis market for resources. This includes, but is not limited to, rare earth elements, precious metals, and herbal supplements. The Company’s goal is to support the medical cannabis industry with innovative products, services, and processes. Green Technology Solutions’ shares trade on the OTCQB.
Fundamentally, the Company works to facilitate the process for patients to get the care they require from their practitioners and eliminate variables that affect the quality of that care. Green Technology Solutions believes it can help in providing a safe and secure environment for the dispensing of medical marijuana and much-needed payment options to give patients easy access to the medicine they require.
Its emphasis on horticultural technology development enables cannabis growers to prosper and patients to receive the quality care they need. The technology includes specialty organic soils and fertilizers storage, growth, and lighting systems, and methods for producing other cannabinoid products. The Company’s development projects aspire to decrease costs for growers and increase the consistency and potency of their product.
Concerning horticultural technology support, streamlining the growing process provides a more consistent and better quality product for consumers. Concerning health & wellness, delivery system products, capsules, topical treatments, vapor inhalants, and drinks undergoing development will enable easier access to medication.
Green Technology Solutions announced this past November that it finalized the purchase of emerging horticultural innovator Mother Parker’s Soil. This company utilizes the latest technologies in soil preparation to provide consumers the highest-quality organic-based products.
Today, Green Technology Solutions announced that it is seeking out new scientific partners who can enhance its expertise in providing pioneering services to the growing Colorado cannabis industry. The Company is close to securing a new location in the heart of Colorado’s cannabis cultivation sector for its recently acquired Class 5 clean room.
This is a germ- and pest-free environment where Green Technology Solutions can reliably test cannabis products for contamination, potency and breeding, among other measurable attributes. The Company acquired the multi-million-dollar asset to commence offering scientific testing and quality-control services to the top cannabis cultivators and retailers. The Company is looking for quality professionals to staff it.
Green Technology Solutions, Inc. (GTSO), closed Tuesday's trading session at $2.06, down 8.02%, on 37,329 volume with 48 trades. The average volume for the last 60 days is 31,968 and the stock's 52-week low/high is $1.29/$11.00.
Barfresh Food Group, Inc. (BRFH)
Wall Street Resources, SmallCapVoice, and OTCJournal reported earlier on Barfresh Food Group, Inc. (BRFH), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.
Barfresh Food Group, Inc. is a manufacturer and distributor of unique, frozen, ready-to-blend beverages. These include smoothies, shakes, as well as frappes. These are chiefly for restaurant chains in the quick serve restaurant (QSR) and casual dining sectors. Barfresh Food Group was previously known as Barfresh Beverage Systems. Barfresh Food Group and Barfresh Food Group Pty Ltd. in Australia (Barfresh Australia) are under common control. The Company is based in Denver, Colorado.
Barfresh Food Group, through its wholly owned subsidiary, Smoothie, Inc., manufactures and distributes ready-to-blend beverages. The Company has acquired the intellectual property (IP) for its unique “ready to blend” ingredient packs (including the patent pending rights) for North America. Its proprietary, U.S. patent-pending system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made smoothies that are quick, cost efficient, and without waste.
The innovative system combines all the ingredients of a quality smoothie into an individually pre-portioned pack. The pack contains real fruit pieces, low fat frozen yogurt or sorbet, fruit juice, and the ice. This is subsequently blended with water to produce a smoothie.
Barfresh Food Group has acquired the exclusive worldwide patent rights to its ready-to-blend beverage packs. This is in addition to its presently held patent rights in the United States and Canada. With this acquisition, it gains exclusive rights to service key global markets. These include, but are not limited to China, Europe, Japan, Brazil, and Australia and New Zealand. The rights acquired by Barfresh include all international patents and trademarks covered under the international Patent Cooperation Treaty.
Barfresh Food Group announced in December 2014 that it secured 20 new retail and institutional accounts in Los Angeles and San Diego, California. The new accounts have signed on to offer its customers Barfresh's unique line of Smoo® smoothies, shakes, and frappes.
This month, Barfresh Food Group announced that it closed a $5.275 million private placement of common stock and warrants to new institutional and accredited investors. The financing will provide the Company with additional working capital to quickly scale new contracts and expand its operations to meet demand for its unique line of Smoo® blended beverages.
Mr. Riccardo Delle Coste, Barfresh Chief Executive Officer, said, "We have recently entered into new distribution partnerships, expanded existing partnerships, enhanced our product line and made key hires on our management team. This funding will allow us to accelerate our growth strategy and satisfy the growing demand for our products by expanding our footprint and enter into additional distribution partnerships, both in the U.S. and abroad."
Barfresh Food Group, Inc. (BRFH), closed Tuesday's trading session at $0.61, up 3.39%, on 264,841 volume with 32 trades. The average volume for the last 60 days is 27,464 and the stock's 52-week low/high is $0.39/$0.85.
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0076, up 2.70%, on 6,626,776 volume with 108 trades. The stock’s average daily volume over the past 60 days is 4,506,701, and its 52-week low/high is $0.0008/$0.1786.
One World Holdings, Inc. today announced it has raised $648,500 from a group of private investors since January 1, 2015. Additionally, One World has obtained purchase order funding commitments up to an additional $950,000. Each of these investments will provide the company with the capital required to carry out the national expansion of The Prettie Girls! and The Prettie Girls! Tween Scene dolls into big box retail stores and assist in the elimination of toxic debt as laid out in the company's debt retirement and consolidation plan announced in 2014.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
One World Holdings Raises Capital to Fund National Expansion and Convertible Note Elimination
The One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call
The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0578, off by 1.20%, on 1,757,330 volume with 102 trades. The stock’s average daily volume over the past 60 days is 531,250, and its 52-week low/high is $0.0555/$0.20.
International Stem Cell Corp. today provided a business update and announced fourth quarter and year-end financial results for the period ended December 31, 2014. Highlights include $7.02 million in revenue for the year ended December 31, 2014, an increase of 14% compared to 2013; Lifeline Skin Care sales up 9% and Lifeline Cell Technology sales up 19%, in addition to gross margin stable at 73%.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces 2014 Fourth Quarter and Year-End Results
International Stem Cell Corporation Receives Key Stem Cell Patent in Japan
International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
Mobile Lads Corp. (MOBO)
The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.106, off by 13.82%, on 28,200 volume with 8 trades. The stock’s average daily volume over the past 60 days is 38,864, and its 52-week low/high is $0.091/$0.42.
Mobile Lads Corp. has commenced operating Simbadeals.com – a world class shopping solution with over four hundred blue chip retailers on the United States site, and with over 30 million products available at all times. Mobile Lads will drive traffic in various ways to its Simbadeals.com website with the aim of converting traffic into sales. Mobile Lads receives 4–15% on sales of merchandise made through the website.
Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.
xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.
xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.
The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.
Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer
Mobile Lads Corp. Company Blog
Mobile Lads Corp. News:
Mobile Lads Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
Mobile Lads Begins Operating North American Shopping Network Simbadeals.com
Mobile Lads Purchases Majority of North American Shopping Network From Domark International
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.005, on 2,482,159 volume with 37 trades. The stock’s average daily volume over the past 60 days is 380,970, and its 52-week low/high is $0.002/$0.8235.
Pure Hospitality Solutions, Inc. announced today, that Oveedia signed its first property Tango Mar Beachfront Boutique Hotel & Villas, in a display of immediate traction for the Central American-Caribbean region specific OTA. This achievement begins the process of securing Pure Hospitality Solution's piece of Latin America's expected 2015 and 2016 online travel sales of $29 Billion and $34 Billion, respectively – according to eMarketer, which referenced economic stats published by Barclays Capital. "It also evidences that Oveedia is already being primed as the region's OTA, even pre-launch," stated Melvin Pereira, President and CEO of Pure Hospitality Solutions
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
Pure's Oveedia Signs First Property
Pure Retains Softon to Accelerate Photo Share Software
PURE's Photo Share To Boost Oveedia Valuations
Start Scientific, Inc. (STSC)
The QualityStocks Daily Newsletter would like to spotlight Start Scientific, Inc. (STSC). Today, Start Scientific, Inc. closed trading at $0.07, up 40.00%, on 3,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 33,724, and its 52-week low/high is $0.05/$0.62.
Operating from headquarters in San Antonio, Texas, Start Scientific, Inc. (STSC) is in continual and aggressive pursuit of its corporate objective to take advantage of oil and gas exploration and development opportunities that are overlooked by mid-sized oil and gas companies.
Start Scientific’s is focused on developing leases and/or joint venture partnerships for its four primary projects in Mississippi, Texas, North Dakota and West Virginia. The projects include shallow, deep, and horizontal drilling opportunities. Geographically, the projects offer the company diversity for exploration and drilling.
As a progressive oil exploration, drilling, extraction and delivery company, Start Scientific relies on the vast knowledge of its management team, which provides more than half a century of combined industry experience. Leveraging strong industry contacts established by company founder Norris R. Harris, Start Scientific also explores partnership and joint-venture opportunities to further accelerate its growth.
Supported by a management team highly experienced in the workings of natural resources and business development, Start Scientific is well-positioned to achieve its mission to explore low-risk land lease opportunities on properties with known oil deposits, develop facilities on these properties to cost effectively extract the oil, and to distribute the refined oil for sale in the open market. Disclaimer
Start Scientific, Inc. Company Blog
Start Scientific, Inc. News:
Start Scientific, Inc. Signs Farmout Agreement With Durban Energy
Start Scientific, Inc. Acquires Option to Purchase 1,500 Acres of Leases in Matagorda County, Texas
Start Scientific, Inc. Signs Farmout Agreement for Flora Field, Madison County, Mississippi
Car Monkeys Group (CKMY)
The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.22, up 10.00%, on 818 volume with 2 trades. The stock’s average daily volume over the past 60 days is 1,294, and its 52-week low/high is $0.10/$5.00.
Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.
With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.
Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.
Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer
Car Monkeys Group Company Blog
Car Monkeys Group News:
Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
Car Monkeys Group (CKMY) is “One to Watch”
Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors
Falcon Crest Energy (FCEN)
The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.0157, up 3.29%, on 12,600 volume with 2 trades. The stock’s average daily volume over the past 60 days is 8,344, and its 52-week low/high is $0.0066/$0.095.
Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.
The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.
Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.
Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer
Falcon Crest Energy Company Blog
Falcon Crest Energy News:
Falcon Crest Energy Acquires Remaining Working Interest in Rocky Ford Field
Falcon Crest Names Michael Cvetanovic to Advisory Council
Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition
Today's Top 3
Trade of the Week
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- eCareer Holdings, Inc. (ECHI) Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities
- International Stem Cell Corp. (ISCO) Announces 2014 Fourth Quarter and Year-End Results
- Inventergy Global, Inc. (INVT) Announces CEO & Chairman Joe Beyers to Present at IPBC Global 2015, San Francisco
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) Raises Capital to Fund National Expansion and Convertible Note Elimination
- Pure Hospitality Solutions, Inc. (PNOW) Pure's Oveedia Signs First Property
- Save The World Air, Inc. (ZERO) Reports 2014 Year-End Financial Results and Provides Operational Update
- Sibling Group Holdings, Inc. (SIBE) Urban Planet Mobile and Rivers Media Group Announce Global Partnership to Deliver Music & Branded Entertainment
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Diversify
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial